reSept ASD Occluder
Secundum Atrial Septal Defect (ASD) closure
Pivotal TrialActive
Key Facts
Indication
Secundum Atrial Septal Defect (ASD) closure
Phase
Pivotal Trial
Status
Active
Company
About atHeart Medical
atHeart Medical is a clinical-stage medical device innovator targeting the structural heart disease market with its novel reSept™ ASD Occluder. The device's key differentiator is its metal-free frame, aiming to set a new standard of care by minimizing the permanent implant footprint and reducing potential long-term complications like erosion, while not limiting future transseptal interventions. The company is currently advancing its pivotal ASCENT ASD IDE trial in the US and internationally, backed by an experienced leadership team and foundational support from its Swiss corporate founder.
View full company profile